Search companies or stocks...
SYRESpyre Therapeutics, Inc.
At close · 01 Sept 2026, 08:00 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Spyre Therapeutics, Inc., a preclinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD). It develops…
Current stock price of Spyre Therapeutics, Inc. (SYRE) stock is $88.500. The stock price is -0.93% lower in the session. The intraday range can be seen from this page. Volume of Spyre Therapeutics, Inc. (SYRE) stock is 1.40M.
Last updated at 01 Sept 2026, 08:00 pm.
The stock price of Spyre Therapeutics, Inc. (SYRE) can change with earnings, company news, and overall market sentiment. Spyre Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether Spyre Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for SYRE on this page is -45.38. EPS on this page is -1.95. Compare those figures with peers and growth expectations before deciding if the current Spyre Therapeutics, Inc. price is justified.
Historical performance for Spyre Therapeutics, Inc. (SYRE) is shown on the price chart on this page. Review multi-period moves alongside volume to see how SYRE reacted to past earnings and market events.
Buying Spyre Therapeutics, Inc. (SYRE) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
